Hissey Kientz L.L.P. Warns Users of Recalled AMO Contact Solution to Substantiate Usage and Contact Their Doctor for Proper Disposal of Contaminated Products

Contrary to the warnings of AMO, Inc, the FDA and the CDC, Hissey Kientz advises users to contact their physician regarding proper disposal of contaminated products.

Austin, TX (PRWEB) June 22, 2007 -- Contrary to the warnings of AMO, Inc, the FDA and the CDC, Hissey Kientz advises users to contact their physician regarding proper disposal of contaminated products.

The firm strongly recommends users of the recalled solution ("AMO Complete") to substantiate usage before disposal.

AMO Complete was recalled by Advanced Medical Optics on May 25, 2007, after the CDC determined that more than half of the patients it interviewed had developed the eye infection Acanthamoeba keratitis after using the solution. The CDC has identified at least 138 Acanthamoeba keratitis infections so far. Doctors estimate that about half of these patients may eventually require a cornea transplant to correct the damage to their eyesight from infection.

Hissey Kientz (http://www.hkllp.com) urges patients to contact their doctors regarding testing and proper disposal. The law firm also recommends that users locate store proof of purchase receipts for AMO Complete solution.

"The FDA's and CDC's primary concern should be to warn users of the dangers associated with this recalled solution, not to discard the only evidence users may have that they were harmed by this dangerous product," says attorney Robert Kientz. "'Government officials are warning people to throw away' contaminated products. (http://biz.yahoo.com/ap/070529/sou_eye_infection_advanced_medical_optics.html?.v=1).

Hissey Kientz urges patients to contact the firm if anyone from the FDA, CDC or AMO directly contacts and instructs users to discard bottles of AMO Complete or contaminated items without first substantiating usage or consulting with their own physician. "The FDA's and CDC's efforts which protect manufacturers of defective or dangerous products do a great disservice to the very people they are charged with protecting," says Kientz.

The first evidence of a link between AMO Complete and Acanthamoeba keratitis was uncovered in 2004, when doctors at a hospital in Illinois treated more than a dozen patients with this rare type of infection. Normally they would receive only one or two cases per year.

After reporting this outbreak to the CDC, a preliminary investigation revealed that thirteen eye centers across the country had experienced a similar rise in Acanthamoeba keratitis cases since 2004.

The CDC determined that AMO Complete were up to seven times more likely to develop the infection than other patients. This led to the recall of AMO Complete.

About Hissey Kientz, LLP

Hissey Kientz, LLP is currently accepting cases involving people affected by mesothelioma, ReNu with MoistureLoc, Fosamax, Tequin, Zelnorm, Avandia, heart devices, Remicade, the Kugel hernia patch, hormone replacement therapy (http://www.hkllp.com) and other defective drugs. To learn more about the firm and other drug cases, visit Hissey Kientz, LLP (www.hkllp.com) or call (866) 275-4454.

###